CROSSROADS STRATEGIES, LLC for GENENTECH, INC.
What was lobbied
6 issue areas, each in the filer's own words, with who lobbied on it and where.
Medicare/Medicaid MMM
General issues related to Medicare and Medicaid, such as: Part D Medicare Program, Medicare Part B reimbursement, and drug pricing. Proposed Part B IPI Demonstration Project. S.551, REFUND Act of 2019. H.R.3, Lower Drug Costs Now Act of 2019. S.2543, Prescription Drug Pricing Reduction Act of 2019. H.R.19, Lower Costs, More Cures Act of 2019. H.R.748, CARES Act (P.L.116-136).
| Lobbyist | Covered position, as disclosed |
|---|---|
| KATHERINE DAPPER | — |
| JASON GLEASON | — |
| JOHN GREEN | — |
| STEWART HALL | — |
| SHAY MICHAEL HANCOCK | — |
| MATHEW LAPINSKI | — |
| HUNTER MOORHEAD | — |
| JASON BENJAMIN VAN PELT | — |
| TODD MATTHEW WEISS | — |
Health Issues HCR
Issues related to health care, the Food and Drug Administration (FDA), 340B Program, drug pricing, importation of biopharmaceuticals, and the international pharmaceutical supply chain. Implementation of Pandemic and All-Hazards Preparedness and Advancing Innovation Act of 2019 (P.L.116-22). S.1895, Lower Health Care Costs Act of 2019. Education around COVID-19 therapies.
| Lobbyist | Covered position, as disclosed |
|---|---|
| KATHERINE DAPPER | — |
| JASON GLEASON | — |
| JOHN GREEN | — |
| STEWART HALL | — |
| SHAY MICHAEL HANCOCK | — |
| MATHEW LAPINSKI | — |
| HUNTER MOORHEAD | — |
| JASON BENJAMIN VAN PELT | — |
| TODD MATTHEW WEISS | — |
Budget/Appropriations BUD
Reimbursement and vial size issues; FY 2021 Departments of Labor, Health and Human Services, and Education, and Related Agencies Appropriations. H.R.6074, Coronavirus Preparedness and Response Supplemental Appropriations Act, 2020 (P.L. 116-123).
| Lobbyist | Covered position, as disclosed |
|---|---|
| KATHERINE DAPPER | — |
| JASON GLEASON | — |
| JOHN GREEN | — |
| STEWART HALL | — |
| SHAY MICHAEL HANCOCK | — |
| MATHEW LAPINSKI | — |
| HUNTER MOORHEAD | — |
| JASON BENJAMIN VAN PELT | — |
| TODD MATTHEW WEISS | — |
Trade (domestic/foreign) TRD
Issues related to the United States-Mexico-Canada Agreement (USMCA). Issues related to biopharmaceutical IP.
| Lobbyist | Covered position, as disclosed |
|---|---|
| KATHERINE DAPPER | — |
| JASON GLEASON | — |
| JOHN GREEN | — |
| STEWART HALL | — |
| SHAY MICHAEL HANCOCK | — |
| MATHEW LAPINSKI | — |
| HUNTER MOORHEAD | — |
| JASON BENJAMIN VAN PELT | — |
| TODD MATTHEW WEISS | — |
Taxation/Internal Revenue Code TAX
Implementation of Tax Cuts and Jobs Act (P.L.115-97).
| Lobbyist | Covered position, as disclosed |
|---|---|
| KATHERINE DAPPER | — |
| JASON GLEASON | — |
| JOHN GREEN | — |
| STEWART HALL | — |
| SHAY MICHAEL HANCOCK | — |
| MATHEW LAPINSKI | — |
| HUNTER MOORHEAD | — |
| JASON BENJAMIN VAN PELT | — |
| TODD MATTHEW WEISS | — |
Copyright/Patent/Trademark CPT
Issues related to pharmaceutical patents; S.1416, Affordable Prescriptions for Patients Act of 2019.
| Lobbyist | Covered position, as disclosed |
|---|---|
| KATHERINE DAPPER | — |
| JASON GLEASON | — |
| JOHN GREEN | — |
| STEWART HALL | — |
| SHAY MICHAEL HANCOCK | — |
| MATHEW LAPINSKI | — |
| HUNTER MOORHEAD | — |
| JASON BENJAMIN VAN PELT | — |
| TODD MATTHEW WEISS | — |
Shown as published by the Senate Office of Public Records and the House Clerk under the Lobbying Disclosure Act. The official filing is the record; open it for the full form.